IMCC - IM Cannabis Corp
0.2997
-0.044 -14.715%
Share volume: 3,084,623
Last Updated: 04-23-2026
Pharmaceutical Products/Medicinal Chemicals:
-0.10%
PREVIOUS CLOSE
CHG
CHG%
$0.34
-0.04
-0.13%
Fundamental analysis
93%
Profitability
100%
Dept financing
50%
Liquidity
75%
Performance
100%
Performance
5 Days
-26.88%
1 Month
-50.02%
3 Months
-78.12%
6 Months
-79.89%
1 Year
-80.41%
2 Year
-85.66%
Key data
Stock price
$0.30
DAY RANGE
$0.28 - $0.34
52 WEEK RANGE
$0.28 - $7.12
52 WEEK CHANGE
-$78.89
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
Company detail
CEO: Oren Shuster
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing
IM Cannabis Corp. engages in breeding, growing, and supply medical cannabis products. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers.
Recent news